Emergent BioSolutions Inc
Veridion Score
Composite trend over time
Why is EBS moving today?
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for EBS.
EBS insider activity
Emergent BioSolutions Inc
No multi-insider buying cluster in the last 90 days
Net selling: -$3.7M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-10 | 2026-06-08 | Hartzel William | Insider | sell | $8.00 | 1,741 | 185,558 | $14K | SEC Form 4 |
| 2026-06-10 | 2026-06-08 | Williams Paul Anthony | Insider | sell | $8.00 | 694 | 162,098 | $6K | SEC Form 4 |
| 2026-06-10 | 2026-06-08 | Glessner Coleen | Insider | sell | $8.00 | 2,018 | 202,201 | $16K | SEC Form 4 |
| 2026-06-10 | 2026-06-08 | LINDAHL RICHARD S | Insider | sell | $8.00 | 3,964 | 374,083 | $32K | SEC Form 4 |
| 2026-05-04 | 2026-05-01 | Zoon Kathryn C | Insider | sell | $8.97 | 1,057 | 79,941 | $9K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 40 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moEBS contract awards, year to date.
Public federal awards linked to this ticker.
EBS lobbying filings, year to date.
Registered lobbying filings matched to Emergent BioSolutions Inc.